TARGETING GANGLIOSIDE GD2 TO OVERCOME CHEMOTHERAPY RESISTANCE IN TRIPLE-NEGATIVE BREAST CANCER

$5,471,258FY2025Defense Health AgencyDOD

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators